Max Planck Innovation licenses analysis-technology for metabolites more
Max Planck Institute of Biochemistry and GlaxoSmithKline enter a research collaboration to develop novel type II diabetes treatments more
Max Planck Innovation and ibidi sign license agreement for cytoskeleton research more
Max Planck Innovation licenses innovative sampling system to bbi-biotech more